Risk Factors Associated with Nosocomial Infections Among End Stage Renal Disease Patients Undergoing Hemodialysis: A Systematic Review

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Jun 23

PMID 32569265

Citations 8

Authors

Saad Hanif Abbasi

Raja Ahsan Aftab

Siew Siang Chua

Affiliations

Soon will be listed here.

Abstract

Background: Profound healthcare challenges confront societies with an increase in prevalence of end-stage renal disease (ESRD), which is one of the leading causes of morbidity and mortality worldwide. Due to several facility and patient related factors, ESRD is significantly associated with increased morbidity and mortality attributed to infections.

Aims And Objective: The aim of this study was to assess systematically the characteristics of patients and risk factors associated with nosocomial infections among ESRD patients undergoing hemodialysis.

Methods: A systematic literature search was performed to identify eligible studies published during the period from inception to December 2018 pertaining to risk factors associated with nosocomial infections among hemodialysis patients. The relevant studies were generated through a computerized search on five databases (PubMed, EBSCOhost, Google Scholar, ScienceDirect and Scopus) using the Mesh Words: nosocomial infections, hospital acquired infections, healthcare associated infections, end stage renal disease, end stage renal failure, hemodialysis, and risk factors. The complete protocol has been registered under PROSPERO (CRD42019124099).

Results: Initially, 1411 articles were retrieved. Out of these, 24 were duplicates and hence were removed. Out of 1387 remaining articles, 1337 were removed based on irrelevant titles and/or abstracts. Subsequently, the full texts of 50 articles were reviewed and 41 studies were excluded at this stage due to lack of relevant information. Finally, nine articles were selected for this review. Longer hospital stay, longer duration on hemodialysis, multiple catheter sites, longer catheterization, age group, lower white blood cell count, history of blood transfusion, and diabetes were identified as the major risk factors for nosocomial infections among hemodialysis patients.

Conclusion: The results of this review indicate an information gap and potential benefits of additional preventive measures to further reduce the risk of infections in hemodialysis population. Moreover, several patient-related and facility-related risk factors were consistently observed in the studies included in this review, which require optimal control measures.

Citing Articles

Infective Endocarditis in Patients with End-Stage Renal Disease on Dialysis: Epidemiology, Risk Factors, Diagnostic Challenges, and Management Approaches.

Issa R, Chaaban N, Salahie A, Honnekeri B, Parizher G, Xu B Healthcare (Basel). 2024; 12(16).

PMID: 39201188 PMC: 11353797. DOI: 10.3390/healthcare12161631.

CVVHDF combined with cytokine adsorption column ameliorates severe catheter-related bloodstream infection in a hemodialysis patient.

Shen Y SAGE Open Med Case Rep. 2024; 12:2050313X241272670.

PMID: 39185073 PMC: 11342434. DOI: 10.1177/2050313X241272670.

Factors Predicting Influenza Vaccination Adherence Among Patients Undergoing Dialysis in Taif City, Saudi Arabia: A Cross-Sectional Study.

Almutairi M, Atalla A Cureus. 2023; 15(6):e40209.

PMID: 37435269 PMC: 10331896. DOI: 10.7759/cureus.40209.

Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data.

Little D, Arnold M, Hedman K, Sun P, Haque S, James G BMC Nephrol. 2023; 24(1):91.

PMID: 37020294 PMC: 10077632. DOI: 10.1186/s12882-023-03119-z.

Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.

Singh J, Stoitsova S, Zakrzewska K, Henszel L, Rosinska M, Duffell E BMC Public Health. 2022; 22(1):2260.

PMID: 36463162 PMC: 9719626. DOI: 10.1186/s12889-022-14726-0.

References

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

Spada E, Abbate I, Sicurezza E, Mariano A, Parla V, Rinnone S . Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy. J Med Virol. 2007; 80(2):261-7. DOI: 10.1002/jmv.21088. View

Qasaimeh G, El Qaderi S, Al Omari G, Al Badadweh M . Vascular access infection among hemodialysis patients in Northern Jordan: incidence and risk factors. South Med J. 2008; 101(5):508-12. DOI: 10.1097/SMJ.0b013e31816c0155. View

Stevenson K, Hannah E, Lowder C, Adcox M, Davidson R, Mallea M . Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002; 39(3):549-55. DOI: 10.1053/ajkd.2002.31405. View

Carrilho F, Moraes C, Pinho J, Mello I, Bertolini D, Lemos M . Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health. 2004; 4:13. PMC: 419975. DOI: 10.1186/1471-2458-4-13. View

Fissell R, Bragg-Gresham J, Woods J, Jadoul M, Gillespie B, Hedderwick S . Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004; 65(6):2335-42. DOI: 10.1111/j.1523-1755.2004.00649.x. View

Fram D, Taminato M, Ponzio V, Manfredi S, Grothe C, Batista R . Risk factors for morbidity and mortality of bloodstream infection in patients undergoing hemodialysis: a nested case-control study. BMC Res Notes. 2014; 7:882. PMC: 4295365. DOI: 10.1186/1756-0500-7-882. View

Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K . Maintenance Dialysis throughout the World in Years 1990 and 2010. J Am Soc Nephrol. 2015; 26(11):2621-33. PMC: 4625679. DOI: 10.1681/ASN.2014101017. View

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y . Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008; 3(5):1526-33. PMC: 4571158. DOI: 10.2215/CJN.00950208. View

10.

Saab S, MARTIN P, BREZINA M, Gitnick G, Yee Jr H . Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Am J Kidney Dis. 2001; 37(2):308-15. DOI: 10.1053/ajkd.2001.21294. View

11.

Sanavi S, Ghods A, Afshar R . Catheter associated infections in hemodialysis patients. Saudi J Kidney Dis Transpl. 2007; 18(1):43-6. View

12.

von Baum H, Schehl J, Geiss H, Schaefer F . Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis. 1999; 29(4):912-6. DOI: 10.1086/520455. View

13.

Gnass M, Gielish C, Acosta-Gnass S . Incidence of nosocomial hemodialysis-associated bloodstream infections at a county teaching hospital. Am J Infect Control. 2014; 42(2):182-4. DOI: 10.1016/j.ajic.2013.08.014. View

14.

Jha V, Li P, Garcia-Garcia G, Couser W, Erk T, Zakharova E . Chronic kidney disease (CKD) in disadvantaged populations. Clin Kidney J. 2015; 8(1):3-6. PMC: 4310427. DOI: 10.1093/ckj/sfu124. View

15.

Song J, Park H, Kang H, Lee J . Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia. BMC Infect Dis. 2017; 17(1):681. PMC: 5639759. DOI: 10.1186/s12879-017-2788-8. View

16.

Schwanke A, Danski M, Pontes L, Kusma S, Lind J . Central venous catheter for hemodialysis: incidence of infection and risk factors. Rev Bras Enferm. 2018; 71(3):1115-1121. DOI: 10.1590/0034-7167-2017-0047. View

17.

Ricks J, Molnar M, Kovesdy C, Shah A, Nissenson A, Williams M . Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes. 2012; 61(3):708-15. PMC: 3282812. DOI: 10.2337/db11-1015. View

18.

Serefhanoglu K, Timurkaynak F, Can F, Cagir U, Arslan H, Ozdemir F . Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis. J Formos Med Assoc. 2012; 111(6):325-32. DOI: 10.1016/j.jfma.2011.03.004. View

19.

Alashek W, McIntyre C, Taal M . Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis. 2012; 12:265. PMC: 3507892. DOI: 10.1186/1471-2334-12-265. View

20.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View